Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study

Background/Aim: We aimed to demonstrate the efficacy and safety of tenofovir disoproxilorotate (TDO) compared with that of tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B. Methods: This multicenter, open-label, prospective clinical trial (KCT0004185) was conducted to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Young, Kim, Sang-Gyune, Jeong, Soung-Won, Jang, Jae-Young, Yoo, Jeong-Ju, Lee, Sae-Hwan, Kim, Young-Seok, Kim, Hong-Soo, Lee, Hyun-Woong, Park, Suyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658686/
https://www.ncbi.nlm.nih.gov/pubmed/34884330
http://dx.doi.org/10.3390/jcm10235628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658686/
https://www.ncbi.nlm.nih.gov/pubmed/34884330
http://dx.doi.org/10.3390/jcm10235628

Ejemplares similares